| If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answer to a multi-variable problem. Withdrawal sequencing, sequence-of-returns risk, Roth conversion timing, and legacy goals can all shift your real number significantly.
Research from Vanguard suggests advisor best practices - covering allocation, rebalancing, tax management, and behavioral coaching - may add roughly 3% in net annual return potential. Morningstar's 2025 data shows the average investor return gap is 1.2% per year due to mistimed buying and selling.
Get matched with a fiduciary advisor in your area at no cost and with no obligation to hire.  |
|
|
| | Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film.
Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.  |
|
| Ex-Dividend Stocks for Thursday, July 23rd |
| | Company | Share Price | Amount / Period | Yield | Previous Amount | Payout Ratio | Payable Date | | AGX Argan | $603.81 | $0.50
quarterly | 0.34% | $0.50 | 17.6% | 7/31/26
| | CVS CVS Health | $110.40 | $0.67
quarterly | 2.55% | $0.67 | 117.2% | 8/3/26
| | DX Dynex Capital | $13.04 | $0.17
monthly | 15.72% | $0.17 | 120.7% | 8/3/26
| | LTC LTC Properties | $42.85 | $0.19
monthly | 5.88% | $0.19 | 92.3% | 7/31/26
| | MRSH Marsh & McLennan Companies | $181.36 | $0.99
quarterly | 2.21% | $0.90 | 45.0% | 8/14/26
| | TEN Tsakos Energy Navigation | $40.17 | $1.00 | 5.15% | - | 16.3% | 7/30/26
| | Please note you must purchase shares of these companies by the market close today to receive the next dividend payment. |
AI doesn't run on chips - it runs on natural gas. Analysts are now tracking roughly 100 gigawatts of new behind-the-meter gas generation lining up behind the AI buildout, and on June 22, one of the world's largest energy companies signed a 20-year, 2.67-gigawatt deal to power a single data-center project.
Ken Griffin has reportedly put more than a billion dollars into this corner of the market. Porter Stansberry has identified two picks-and-shovels plays in AI's power supply, plus 6 stocks to buy and 10 to sell - all detailed in a new documentary.  |
|
Ex-Dividend Stocks for Friday, July 24th |
| | Company | Share Price | Amount / Period | Yield | Previous Amount | Payout Ratio | Payable Date | | ACI Albertsons Companies | $14.70 | $0.17
quarterly | 4.66% | $0.17 | 212.5% | 8/7/26
| | BUSE First Busey | $29.89 | $0.26
quarterly | 3.54% | $0.26 | 46.2% | 7/31/26
| | CNXC Concentrix | $23.79 | $0.36
quarterly | 5.71% | $0.36 | -6.8% | 8/4/26
| | COKE Coca-Cola Consolidated | $183.09 | $0.25
quarterly | 0.56% | $0.25 | 13.7% | 8/7/26
| | COST Costco Wholesale | $929.22 | $1.47
quarterly | 0.62% | $1.47 | 29.6% | 8/7/26
| | FSCO FS Credit Opportunities | $4.98 | $0.06
monthly | 14.41% | $0.06 | - | 7/31/26
| | GEHC GE HealthCare Technologies | $62.04 | $0.04
quarterly | 0.22% | $0.04 | 3.3% | 8/14/26
| | KALU Kaiser Aluminum | $164.37 | $0.77
quarterly | 1.95% | $0.77 | 33.6% | 8/14/26
| | LKFN Lakeland Financial | $62.11 | $0.52
quarterly | 3.37% | $0.52 | 48.7% | 8/5/26
| | NVT nVent Electric | $160.36 | $0.21
quarterly | 0.52% | $0.21 | 27.9% | 8/7/26
| | PFE Pfizer | $24.91 | $0.43
quarterly | 7.15% | $0.43 | 131.3% | 9/1/26
| | PG Procter & Gamble | $148.12 | $1.09
quarterly | 2.98% | $1.09 | 63.6% | 8/17/26
| | PNR Pentair | $61.55 | $0.27
quarterly | 1.40% | $0.27 | 26.5% | 8/7/26
| | SIG Signet Jewelers | $90.39 | $0.35
quarterly | 1.59% | $0.35 | 13.5% | 8/21/26
| | TYG Tortoise Energy Infrastructure | $44.19 | $0.48
monthly | 12.36% | $0.48 | - | 7/31/26
| | UNM Unum Group | $88.40 | $0.51
quarterly | 2.29% | $0.46 | 40.0% | 8/14/26
| | Please note you must purchase shares of these companies by the market close tomorrow to receive the next dividend payment. |
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles — a disease with no approved antiviral treatment currently on the market.
NV-387 is designed as a broad-spectrum antiviral with potential applications across RSV, influenza, coronaviruses, Mpox, and more. With Phase II trials advancing and measles cases resurging globally, NNVC is entering a notable inflection point.  |
|
Ex-Dividend Stocks for Monday, July 27th |
| | Company | Share Price | Amount / Period | Yield | Previous Amount | Payout Ratio | Payable Date | | BCO Brink's | $123.03 | $0.26
quarterly | 0.98% | $0.26 | 23.8% | 9/1/26
| | LPG Dorian LPG | $44.39 | $1.00
special | - | - | - | 8/12/26
| | RY Royal Bank Of Canada | $210.99 | $1.76
quarterly | 2.70% | $1.64 | 44.5% | 8/24/26
| | USAC USA Compression Partners | $26.99 | $0.53
quarterly | 7.81% | $0.53 | 216.5% | 8/7/26
| | WMK Weis Markets | $77.35 | $0.34
quarterly | 1.71% | $0.34 | 33.0% | 8/10/26
| | Please note you must purchase shares of these companies by the market close tomorrow to receive the next dividend payment. |
| Dividend Stock IdeasThis is a list of companies that meet common criteria that investors use to evaluate dividend stocks. This list contains companies that have dividend yields greater than 3%, payout ratios of less than 75% (or less than 100% for REITs), five-year average annual dividend growth of at least 1.5% and a minimum market cap of $1 billion. |
| | Company | Dividend Yield | Annual Payout | Payout Ratio | Annual Dividend Growth | P/E Ratio | Market Cap | | TBCG TBC Bank Group PLC | 5.33% | GBX 1,067.01 | 41.39% | 5.29% | 1.88 | £2.66K | | FSK FS KKR Capital Corp. | 15.37% | $1.68 | N/A | 1.81% | N/A | $3.04K | | BGEO Lion Finance Group PLC | 4.59% | GEL 1,622.58 | 31.57% | 4.90% | 2.25 | GEL498.32K | | WPP WPP plc | 5.31% | GBX 31.90 | N/A | 4.75% | N/A | £2.89K | | EFC Ellington Financial Inc. | 11.63% | $1.56 | 93.98% | 4.36% | 8.14 | $1.68K | | PRGO Perrigo Company plc | 10.82% | $1.16 | N/A | 5.21% | N/A | $1.47K |
| |
|
